Immuron Ltd — Regulatory Filings 2009

Sep 1, 2009

Wilmoth Field Warne Lawyers ABN 33 220 647 391

Level 13, 440 Collins St Melbourne 3000 Victoria Australia

Telephone +61 3 9224 1000 Facsimile +61 3 9224 1099 DX 289 Melbourne

Email info@wfw.com.au Website www.wfw.com.au

FACSIMILE

ATTENTION:	Company Announcements Office
COMPANY:	ASX Limited
FROM:	Wilmoth Field Warne	OUR REF:	12909
TO FAX NO:	1300 135 638	CONTACT:	Marc Davies
$\mathsf{DATE}$ :	2 September 2009	PARTNER:	Gary Herz
VO. OF PAGES:	5 pages (including cover page)

HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED FORM 603 - NOTICE OF INTIAL SUBSTANTIAL HOLDER

Please find letter enclosed.

Yours faithfully WILMOTH FIELD WARNE

WFW Per:

This facsimile transmission contains privileged or confidential information intended only for the addressee. Unauthorised use of the information is prohibited. If you have received this transmission by mistake do not copy the transmission or communicate its content to any person. Please telephone Wilmoth Field Warne immediately reverse charge (if necessary) to advise the error.

F:\matters\12909\c\FL ASX 00.01 (02.09.09) .doc

Wilmoth Field Warne Lawyers ABN 33 220 647 391

Level 13, 440 Collins St Melbourne 3000 Victoria Australia

Telephone +61 3 9224 1000 Facsimile +61 3 9224 1099 DX 289 Melbourne VIC

Email info@wfw.com.au Website www.wfw.com.au

Our Ref: 12909 Partner: Gary Herz Contact: Marc Davies

2 September 2009

Company Announcements Office ASX Limited Level 45, South Tower, Rialto Towers 525 Collins Street Melbourne VIC 3000

WILMOTHFIELDWARNE

LAWYERS

BY FACSIMILE: 1300 135 638

Dear Sirs

HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED FORM 603 - NOTICE OF INTIAL SUBSTANTIAL HOLDER

We act for Hadasit Medical Research Services & Development Limited (a company incorporated in Israel).

Pursuant to section 671B(1)(a) of the Corporations Act 2001 (Cth) we enclose a Form 603 Notice of Initial Substantial Holder in relation to Immuron Limited ACN 063 114 045.

A copy of this notice has been provided to Immuron Limited.

Yours faithfully WILMOTH FIELD WARNE

Per: WFW

Enclosure

i g

			603		page 1/2 15 July 2001
		Form 603 Corporations Act 2001 Section 671B
		Notice of initial substantial holder
In Company Name/Scheme		Immuron Limited
ACN/ARSN	063 114 045
7. Details of substantial holder (1) Name ACN/ARSN (If applicable)		Radasit Medical Research Services & Development Ltd (Hadasit)

1. Details of voting power

The holder bestime a substantial holder on

and the boundary of the set of the world shares in the company or voting interests in the scheme that the substantial holder or an acsociate (2) had a
The total number of votas attacked the substantial holder became a subs

$27/8/09$

Class of securities (4) .	----- Number of securities	Person's votes (5)	Voting power (6)
10RD	96966139 --------	46966139	19.99%
			delivery consequence and a

3. Details of rolarant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest	Nature of relevant interest (7)	Class and number of securities
Hadasit	Holder of securities	ORD

4. Details of present registered holders

The parsons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder or rolevant Interast	Registered holder of Socurities	Person entitled to be registered as holder (8)	Class and number of securities
Hadasit	Hadasit	Hadasit	ORD

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a
substantial holder is as follows:

__ Holder of relevant interest	Date of acquisiting	Consideration (9)		Class and number of securities
		Cash	মচানক্ৰয়ন	Middleburg Company Company
Hadasit	27/8/09	N11	Annexure	46966139

	6. Associates	The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:
		Name and ACN/ARSN (If applicable)		Neture of association
	7. Addresses
		The addresses of persons named in this form are as follows: Name
		Hadasit	Address		PO Box 12000, Jerusalem 91120
	Signature	print name	Dr. EINAT ZISMAN CEO Hadasit Medical Research Services
		sign here	& Development Ltd.				capacity
						date			०५
					DEPUTY DIRECTOR GENERAL FINANCT	MENACHEM RATZ
			DIRECTIONS
O)		If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of en equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are cssentially similar, they may be referred to throughout the form as a specifically named group if the mombership of each group, with the names and addresses of members is clearly set out in percyraph 7 of the
a 周		See the definition of "associate" in section 9 of the Corporations Act 2001. See the definition of "relevant interest" in sections 608 and 6719(7) of the Corporations Act 2001.			÷.
(4)		The voting shares of a company constitute one class unless divided into separate classes.
G)		The total number of votes attached to ail the voting shapes in the company or voting interests in the scheme (if any) that the person or an associate has a relevant
侚		The person's votes divided by the total votes in the body corporate or scheme multiplied by 103.
ω	(a)	Include details of: any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 6718(4) applies, a copy of any documant setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract. Scheme or arrangement, must accompany
	D)	this form, together with a written sustement certifying this contract, scheme or arrangement; and any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to
		which the relevant interest relates (indicating clearly the particular securities to which the qualification applies). See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
侧,		If the substantial holder is unable to datermine the identity of the person (eg. If the relevant interest arises because of an option) write "unknown".
9.		Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included oven if the benefit is conditional on the happening or not of a contingency. Details must be included of any bondit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom

. . . . . . . .

ý

ANNEXURE A

HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED

This is Annexure A of 1 page referred to in
ASIC Form 603 Notice of Initial Substantial Holder

Relevant interests

This transaction took place on a prescribed financial market.

Consideration

Assignment of Intellectual property pursuant to an Assignment and Licence Agreement dated 17 April 2009. and Deed of Variation detector 22nd July 2009.

$\sim$ $^{-1}$

Signed:		Date: ິ	$\circ$
Print name:	Dr. EINAT ZISMAN CEO Hadasit Medical Research Services & Development Ltd.	MENACHEM 长さ DEPUTY DIRT GENERAL FOR	Page 1 of 1